Predictive value of combining the level of lipoprotein-associated phospholipase A2 and antithrombin III for acute coronary syndrome risk
- PMID: 30546880
- PMCID: PMC6256189
- DOI: 10.3892/br.2018.1162
Predictive value of combining the level of lipoprotein-associated phospholipase A2 and antithrombin III for acute coronary syndrome risk
Abstract
The aim of the present study was to observe the role of lipoprotein-associated phospholipase A2 (Lp-PLA2) and antithrombin III (AT-III) in patients with acute coronary syndrome (ACS), and the combination of Global Registry of Acute Coronary Events (GRACE) score to determine the value of coronary heart disease risk stratification. A total of 309 patients admitted to the Affiliated Hospital of Xuzhou Medical University were enrolled. The patients were divided into two groups: The ACS (183 cases) and control (126 cases) groups. Blood levels of Lp-PLA2 and AT-III were measured. Based on GRACE score, the patients with ACS were divided into three subgroups: Low risk (GRACE score ≤108), middle risk (GRACE score 109-140) and high risk (GRACE score >140). The levels of Lp-PLA2 and AT-III were compared among different groups, and based on Gensini score, patients with ACS were divided into four groups by quartiles. Lp-PLA2 levels in the ACS group were significantly increased compared with the control group (P<0.05), but the AT-III levels were decreased compared with the control group (P<0.05). In the ACS group, Lp-PLA2 levels increased sequentially from the low risk to high risk subgroups (all P<0.05); compared with the low risk and middle risk subgroups, the AT-III activity levels were decreased in the high risk subgroup, and the Gensini scores were increased (all P<0.05). In the ACS group, with the increase of Gensini scores, the levels of Lp-PLA2 and AT-III exhibited increasing and decreasing trends, respectively (P<0.05). The logistic regression model demonstrated that Lp-PLA2 [odds ratio (OR) =1.077; P<0.001]; and GRACE score (OR=1.026; P=0.028) were risk factors, while AT-III was a protective factor (OR=0.958; P=0.012) for ACS. Correlation analysis indicated a positive association of Lp-PLA2 level with Gensini scores (r=0.52; P<0.01) and GRACE score (r=0.48; P<0.01), and a negative association between AT-III level and Gensini scores (r=-0.25; P<0.01) and GRACE scores (r=-0.34; P<0.01). The levels of Lp-PLA2 and AT-III exhibited predictive values in patients with ACS, and are associated with the severity of coronary artery stenosis.
Keywords: GRACE score; acute coronary syndrome; antithrombin III; lipoprotein-associated phospholipase A2.
Similar articles
-
Association between serum lipoprotein-associated phospholipase A2, ischemic modified albumin and acute coronary syndrome: a cross-sectional study.Heart Vessels. 2019 Oct;34(10):1608-1614. doi: 10.1007/s00380-019-01403-3. Epub 2019 Apr 8. Heart Vessels. 2019. PMID: 30963302
-
Change of Inflammatory Factors in Patients with Acute Coronary Syndrome.Chin Med J (Engl). 2018 Jun 20;131(12):1444-1449. doi: 10.4103/0366-6999.233953. Chin Med J (Engl). 2018. PMID: 29893361 Free PMC article.
-
Association between the serum lipoprotein-associated phospholipase A2 level and acute coronary syndrome.Cardiovasc J Afr. 2023 Nov-Dec 23;34(5):273-277. doi: 10.5830/CVJA-2022-056. Epub 2023 Jan 11. Cardiovasc J Afr. 2023. PMID: 36637451 Free PMC article.
-
Lipoprotein-associated phospholipase A2 in coronary heart disease: Review and meta-analysis.Clin Chim Acta. 2017 Feb;465:22-29. doi: 10.1016/j.cca.2016.12.006. Epub 2016 Dec 9. Clin Chim Acta. 2017. PMID: 27956130 Review.
-
HEART versus GRACE Score in Predicting the Outcomes of Patients with Acute Coronary Syndrome; a Systematic Review and Meta-Analysis.Arch Acad Emerg Med. 2023 Jul 19;11(1):e50. doi: 10.22037/aaem.v11i1.2001. eCollection 2023. Arch Acad Emerg Med. 2023. PMID: 37609535 Free PMC article. Review.
Cited by
-
Mediation effect of antithrombin III between chronic renal insufficiency and chronic coronary artery disease in T2DM patients.Endocrine. 2024 Jun;84(3):924-933. doi: 10.1007/s12020-023-03669-0. Epub 2024 Jan 8. Endocrine. 2024. PMID: 38190026
-
An Updated Review of Lysophosphatidylcholine Metabolism in Human Diseases.Int J Mol Sci. 2019 Mar 6;20(5):1149. doi: 10.3390/ijms20051149. Int J Mol Sci. 2019. PMID: 30845751 Free PMC article. Review.
-
Predictive value of combining the level of fibrinogen and antithrombin III for contrast-induced nephropathy in coronary artery disease patients undergoing percutaneous coronary intervention.Biomed Rep. 2020 Oct;13(4):26. doi: 10.3892/br.2020.1333. Epub 2020 Jul 22. Biomed Rep. 2020. PMID: 32765865 Free PMC article.
-
Association between serum lipoprotein-associated phospholipase A2, ischemic modified albumin and acute coronary syndrome: a cross-sectional study.Heart Vessels. 2019 Oct;34(10):1608-1614. doi: 10.1007/s00380-019-01403-3. Epub 2019 Apr 8. Heart Vessels. 2019. PMID: 30963302
-
Joint association of remnant cholesterol and lipoprotein-associated phospholipase A2 with composite adverse events: A 12-year follow-up study from Asymptomatic Polyvascular Abnormalities Community study.Diabetes Obes Metab. 2025 May;27(5):2790-2799. doi: 10.1111/dom.16286. Epub 2025 Mar 4. Diabetes Obes Metab. 2025. PMID: 40035211 Free PMC article.
References
-
- Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2095–2128. doi: 10.1016/S0140-6736(12)61728-0. - DOI - PMC - PubMed
-
- Dong L, Qu X, Hu ZG, Peng X, Wang Y, Miao Q, Zhang X. Lipoprotein-associated phospholipase A2 is associated with angiographic coronary artery disease and coronary artery risk factors in the elderly. Int J Gerontol. 2015;9:82–86. doi: 10.1016/j.ijge.2015.05.005. - DOI
-
- Ikonomidis I, Kadoglou NN, Tritakis V, Paraskevaidis I, Dimas K, Trivilou P, Papadakis I, Tzortzis S, Triantafyllidi H, Parissis J, et al. Association of Lp-PLA2 with digital reactive hyperemia, coronary flow reserve, carotid atherosclerosis and arterial stiffness in coronary artery disease. Atherosclerosis. 2014;234:34–41. doi: 10.1016/j.atherosclerosis.2014.02.004. - DOI - PubMed
LinkOut - more resources
Full Text Sources